Skip to main content
Top
Published in: Clinical and Translational Oncology 4/2007

01-04-2007 | RESEARCH ARTICLES

Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck

Authors: A. Biete Solà, J. Marruecos Querol, F. A. Calvo Manuel, E. Verger Fransoy, À. Rovirosa Casino, J. J. Grau de Castro, M. de las Heras González, A. Ramos Aguerri, A. Palacios Eito, C. Veiras Candal, Mª. V. Solano López

Published in: Clinical and Translational Oncology | Issue 4/2007

Login to get access
Metadata
Title
Phase II trial: concurrent radio-chemotherapy with weekly docetaxel for advanced squamous cell carcinoma of head and neck
Authors
A. Biete Solà
J. Marruecos Querol
F. A. Calvo Manuel
E. Verger Fransoy
À. Rovirosa Casino
J. J. Grau de Castro
M. de las Heras González
A. Ramos Aguerri
A. Palacios Eito
C. Veiras Candal
Mª. V. Solano López
Publication date
01-04-2007
Publisher
Springer-Verlag
Published in
Clinical and Translational Oncology / Issue 4/2007
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/s12094-007-0047-y

Other articles of this Issue 4/2007

Clinical and Translational Oncology 4/2007 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine